These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Recent developments with tau-based drug discovery. Iqbal K; Liu F; Gong CX Expert Opin Drug Discov; 2018 May; 13(5):399-410. PubMed ID: 29493301 [TBL] [Abstract][Full Text] [Related]
25. The effects of O-GlcNAc alteration on Alzheimer-like neurodegeneration in SK-N-SH cells. Ding N; Peng P; Chu YJ; Wang JJ; Chen SY; Arulthas R; Deng YQ Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):243-248. PubMed ID: 30181664 [TBL] [Abstract][Full Text] [Related]
26. Discovery of 4-(Arylethynyl)piperidine Derivatives as Potent Nonsaccharide Cheng Z; Shang N; Wang X; Kang Y; Zhou J; Lan J; Hu J; Peng Y; Xu B J Med Chem; 2024 Aug; 67(16):14292-14312. PubMed ID: 39109492 [TBL] [Abstract][Full Text] [Related]
27. Alzheimer's disease: phenotypic approaches using disease models and the targeting of tau protein. Lauretti E; Praticò D Expert Opin Ther Targets; 2020 Apr; 24(4):319-330. PubMed ID: 32116063 [No Abstract] [Full Text] [Related]
28. Development of a PET Tracer for OGA with Improved Kinetics in the Living Brain. Cook BE; Nag S; Arakawa R; Lin EY; Stratman N; Guckian K; Hering H; Lulla M; Choi J; Salinas C; Genung NE; Morén AF; Bolin M; Boscutti G; Plisson C; Martarello L; Halldin C; Kaliszczak MA J Nucl Med; 2023 Oct; 64(10):1588-1593. PubMed ID: 37934021 [No Abstract] [Full Text] [Related]
29. Yeast cells as an assay system for in vivo O-GlcNAc modification. Nakanishi H; Li F; Han B; Arai S; Gao XD Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870 [TBL] [Abstract][Full Text] [Related]
30. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription. Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148 [TBL] [Abstract][Full Text] [Related]
31. Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies. Mellone M; Kestoras D; Andrews MR; Dassie E; Crowther RA; Stokin GB; Tinsley J; Horne G; Goedert M; Tolkovsky AM; Spillantini MG J Neurosci; 2013 Nov; 33(46):18175-89. PubMed ID: 24227726 [TBL] [Abstract][Full Text] [Related]
32. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration. Gong CX; Liu F; Iqbal K Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545 [TBL] [Abstract][Full Text] [Related]
33. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain. Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023 [TBL] [Abstract][Full Text] [Related]
35. A genetic model to study St Amand MM; Bond MR; Riedy J; Comly M; Shiloach J; Hanover JA J Biol Chem; 2018 Aug; 293(35):13673-13681. PubMed ID: 29954943 [No Abstract] [Full Text] [Related]
37. Discovery of MK-8719, a Potent O-GlcNAcase Inhibitor as a Potential Treatment for Tauopathies. Selnick HG; Hess JF; Tang C; Liu K; Schachter JB; Ballard JE; Marcus J; Klein DJ; Wang X; Pearson M; Savage MJ; Kaul R; Li TS; Vocadlo DJ; Zhou Y; Zhu Y; Mu C; Wang Y; Wei Z; Bai C; Duffy JL; McEachern EJ J Med Chem; 2019 Nov; 62(22):10062-10097. PubMed ID: 31487175 [TBL] [Abstract][Full Text] [Related]
38. Thiamet-G-mediated inhibition of O-GlcNAcase sensitizes human leukemia cells to microtubule-stabilizing agent paclitaxel. Ding N; Ping L; Shi Y; Feng L; Zheng X; Song Y; Zhu J Biochem Biophys Res Commun; 2014 Oct; 453(3):392-7. PubMed ID: 25268318 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of a PET Radioligand to Image Paul S; Haskali MB; Liow JS; Zoghbi SS; Barth VN; Kolodrubetz MC; Bond MR; Morse CL; Gladding RL; Frankland MP; Kant N; Slieker L; Shcherbinin S; Nuthall HN; Zanotti-Fregonara P; Hanover JA; Jesudason C; Pike VW; Innis RB J Nucl Med; 2019 Jan; 60(1):129-134. PubMed ID: 30213846 [TBL] [Abstract][Full Text] [Related]
40. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells. de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]